Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. - Wikidata - wikimedia - TriplyDB

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

http://www.wikidata.org/entity/Q53239672

about

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis Adverse effects of biologics: a network meta-analysis and Cochrane overview Abatacept for rheumatoid arthritis Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study Biologic interventions for fatigue in rheumatoid arthritis Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review My treatment approach to rheumatoid arthritis Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies Immunotherapy in autoimmune type 1 diabetes Subcutaneous abatacept for the treatment of rheumatoid arthritis.Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy Combination therapy with biologic agents in rheumatic diseases: current and future prospects New pharmacological strategies in rheumatic diseases Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.[Phase IV non-interventional studies in the treatment of rheumatoid arthritis with biologicals in Germany : real-life clinical practice data].Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment.Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials.Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept.Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.Biologics and heart failure in rheumatoid arthritis: are we any wiser?Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate.Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.Rationale of using different biological therapies in rheumatoid arthritis.Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trials Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis Abatacept: the evidence for its place in the treatment of rheumatoid arthritis.Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70 Abatacept: a novel therapy approved for the treatment of patients with rheumatoid arthritis.

P2860

Q24185797-B4D3C59A-C84B-433F-840F-0746D7971CEA Q24234197-52684CD8-D177-4016-A934-F31BB3195B84 Q24240131-680BC24D-746C-4EF6-A6F4-9F198621D69B Q24630541-22AC0B83-701A-4FC7-ADFB-174916DF7A18 Q26471538-5B687BC9-98B1-404A-A948-9A48549EC97B Q26774874-0832CFA9-6234-4B74-A9BC-6E2EA9CFD848 Q26829955-DED63627-E4CB-4188-8F54-FB284F9183BD Q26991673-97F78077-D5FA-4DF9-B09C-1D02A23418DD Q27025619-788FBA8F-8168-4BE2-AD22-1350BD472132 Q27692117-7E8BA7A1-5B4E-488A-948B-882EF7D6037A Q27694496-4B5F1507-DFC2-45B1-8AB0-DBE7BC4DD133 Q28066250-3B62F990-A5BA-4EA5-B7C8-57D01DB06069 Q28073763-ED5D8980-6730-4848-A9E0-0F15B34171CA Q28543128-FD24164D-9576-4C36-9EC9-B74AF29B42D6 Q28547851-86148B51-8F3E-4682-BF08-D8256A659FB1 Q30234528-0830FA7C-A864-4B29-A514-97EE6FABF574 Q30235341-1782FFB3-761C-483C-8C64-C861DBEECB13 Q30699616-9275FAD5-FEB6-4A10-8291-01150CF415BC Q30811550-7F709360-2A41-4A3A-8F61-07F997AE6A38 Q30863740-D52D5C7A-C72C-4841-B8BB-891A43D1BF92 Q30914777-C5F90E13-1676-4278-8E09-2C98C591B8EA Q33315300-EB8BAA0B-7470-4AB6-B33C-FEDD75CFD8A8 Q33392167-FD99E57A-8C71-49BE-8AE1-7FFD87749C7D Q33725521-E25CA645-C29C-447D-AFCE-8B96A6C9664D Q33754764-99EF313C-210A-44B9-9627-2036F7085347 Q33809045-E1466FC4-1C31-4AAC-9921-A8B07DCB1529 Q33819684-9EC7DFD1-D901-4DB0-A945-0AD86728C8C5 Q33898103-F924226C-2BBD-4925-9B25-5C10EF699C43 Q33923452-7D11D046-B5D1-4D95-AAA0-FAC078CF173A Q33962865-CFF1CD5F-1068-4087-8C3A-9DEC39EE269B Q34001621-81061BD5-08F1-4C59-9093-F9F9D0F92EEB Q34110049-BBE03122-49E7-448B-9BB2-4AF2D3C64DA7 Q34124686-A6F4CA82-BF13-4498-B1E3-5FA3C9E3E206 Q34153073-70BBFC20-E183-4C6B-943F-E60097A8CA1F Q34343286-BBB273B2-3F3B-4F95-A8CC-BC730656A279 Q34364057-8AC04318-66A7-46B6-99F7-91B549878C98 Q34411088-0B0B70B5-8CFD-41FC-80B4-07134DF22263 Q34449851-40C7A0C3-7BAA-4605-8BB9-4B090F77BFD6 Q34523450-C2361543-ABD7-4270-9619-0466748B8288 Q34580298-0FF28253-1E2B-4CE4-A9FC-78B220767A18

P2860

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

http://www.wikidata.org/entity/Q53239672

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en-gb

Effects of abatacept in patien ...... arthritis: a randomized trial.

@nl

type

label

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en-gb

Effects of abatacept in patien ...... arthritis: a randomized trial.

@nl

prefLabel

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en-gb

Effects of abatacept in patien ...... arthritis: a randomized trial.

@nl

P1433

Q53239672-EB2FB821-6F78-48AD-99CA-EB902F61D6EF

P1476

Q53239672-F9939B91-A5B2-49C5-B78C-243F79BE3599

P2093

Q53239672-114C69F7-E5BF-4826-8273-9138797BF404

Q53239672-2E5F8978-FB46-4126-BA79-78D481D3C0CC

Q53239672-3803984F-6E93-4B17-81D6-E4E0CA5E507B

Q53239672-5FB272FF-10AA-496E-97E6-2B4228D63D8F

Q53239672-63D71023-3F3C-4D89-9815-6501D028A563

Q53239672-8AF88143-106D-4646-AE42-F058850E5928

Q53239672-8FBDE192-9548-43DD-9B7C-31A1C856AD04

Q53239672-D92F9DD2-94D3-46AC-A93A-AACF89E1C560

Q53239672-E60BA3FE-A44B-4BE5-82EA-B910D74D9315

Q53239672-F298C81B-ACE1-4956-B748-D6D6B6AD20C4

P304

Q53239672-5469F08F-3B1D-441E-BD6E-C1204480E05E

P31

Q53239672-AA8F460B-8B39-486D-A0F8-79231D2681AB

P356

Q53239672-AE8D99A6-EF1A-46AF-B6F9-C6626630F53E

P407

Q53239672-F2DBA094-F935-4683-8673-6DF14B9B38D0

P433

Q53239672-82F952BE-9091-40DF-BAC5-84EF59294FB6

P478

Q53239672-17034846-E40F-4072-B1EC-01A72F15DF2E

P50

Q53239672-1D5E4941-4F4E-40AE-A1BD-190F8B9D3EFB

P577

Q53239672-EDCC4486-9866-4A8F-8EAF-F1F2B5E41FF8

P698

Q53239672-00AD535C-2B02-4645-BDD5-A132390CD454

P921

Q53239672-A3884729-04FC-462F-8FBE-1D931EA8C8FA

P356

0003-4819-144-12-200606200-00003

P1433

Annals of Internal Medicine

P1476

Effects of abatacept in patien ...... arthritis: a randomized trial.

@en

P2093

Anthony S Russell

http://www.w3.org/2001/XMLSchema#string

Carlos Abud-Mendoza

http://www.w3.org/2001/XMLSchema#string

Harry K Genant

http://www.w3.org/2001/XMLSchema#string

Jacek Szechinski

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Becker

http://www.w3.org/2001/XMLSchema#string

Joel M Kremer

http://www.w3.org/2001/XMLSchema#string

Larry W Moreland

http://www.w3.org/2001/XMLSchema#string

Rene Westhovens

http://www.w3.org/2001/XMLSchema#string

Tracy Li

http://www.w3.org/2001/XMLSchema#string

Zhiyu Ge

http://www.w3.org/2001/XMLSchema#string

P304

865-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-144-12-200606200-00003

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16785475

http://www.w3.org/2001/XMLSchema#string

P921